Compounds > 6-methylene-4-pregnene-3,20-dione

Page last updated: 2024-09-03

6-methylene-4-pregnene-3,20-dione and Prostatic Neoplasms

6-methylene-4-pregnene-3,20-dione has been researched along with Prostatic Neoplasms in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (66.67)	18.7374
1990's	2 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Marts, SA; Mukherji, S; Padilla, GM; Petrow, V	2
Padilla, GM; Petrow, V; Roberson, KM; Robertson, CN; Schmidt, JM	1
Bergh, A; Daehlin, L; Damber, JE; Landström, M; Petrow, V	1
Ito, YZ; Nakazato, Y; Petrow, V	1
Petrow, V	1

Reviews

1 review(s) available for 6-methylene-4-pregnene-3,20-dione and Prostatic Neoplasms

Article	Year
The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications. The Prostate, 1986, Volume: 9, Issue:4 Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Adenocarcinoma; Animals; Dihydrotestosterone; Humans; Male; Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Progesterone; Prostate; Prostatic Neoplasms; Rats; Testosterone	1986

Other Studies

5 other study(ies) available for 6-methylene-4-pregnene-3,20-dione and Prostatic Neoplasms

Article	Year
Endocrine dependence of prostatic cancer upon dihydrotestosterone and not upon testosterone. The Journal of pharmacy and pharmacology, 1984, Volume: 36, Issue:5 Topics: Adenocarcinoma; Animals; Cells, Cultured; Dihydrotestosterone; Male; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Progesterone; Prostatic Neoplasms; Rats; Testosterone	1984
6-Methylene progesterone is cytotoxic to human cancer cell lines independent of its 5-alpha-reductase activity. The Prostate, 1995, Volume: 26, Issue:1 Topics: Cholestenone 5 alpha-Reductase; Female; Humans; Male; Oxidoreductases; Progesterone; Prostatic Neoplasms; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms	1995
Effects of 6-methylene progesterone on growth, morphology, and blood flow of the Dunning R3327 prostatic adenocarcinoma. The Prostate, 1992, Volume: 20, Issue:3 Topics: Adenocarcinoma; Animals; Male; Orchiectomy; Progesterone; Prostatic Neoplasms; Rats; Rats, Inbred F344; Regional Blood Flow	1992
A new approach to prostate cancer. The Journal of pharmacy and pharmacology, 1989, Volume: 41, Issue:7 Topics: Adenoma; Animals; Disease Models, Animal; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Organ Size; Progesterone; Prostate; Prostatic Neoplasms; Seminal Vesicles	1989
Approaches to prostatic cancer chemotherapy using the Dunning R3327H prostatic adenocarcinoma. The Prostate, 1985, Volume: 6, Issue:2 Topics: 5-alpha Reductase Inhibitors; Adenocarcinoma; Animals; Carrier Proteins; Disease Models, Animal; Estramustine; Male; Neoplasm Transplantation; Organ Size; Progesterone; Prostate; Prostatic Neoplasms; Prostatic Secretory Proteins; Rats; Structure-Activity Relationship	1985